Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Tomer Ben-Kiki was appointed as Chief Operating Officer at DarioHealth Corp..
- Action
- appointed
- Role
- Chief Operating Officer
Exact text from the filing
On February 15, 2024, the Company appointed Tomer Ben-Kiki, age 53, as Chief Operating Officer of the Company.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
DarioHealth Corp. entered into Agreement and Plan of Merger with Twill, Inc. (effective 2024-02-15).
- Action
- entry
- Agreement
- merger
- Counterparty
- Twill, Inc.
- Effective
- 2024-02-15
Exact text from the filing
(“Merger Sub”), Twill, Inc. (“Twill”) and Bilal Khan, solely in his capacity as the representatives of Twill’s stockholders and other equity holders, entered into an Agreement and Plan of
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
DarioHealth Corp. entered into Series C Purchase Agreement with accredited investors valued at approximately $22,422,000 (effective 2024-02-15).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- accredited investors
- Value
- approximately $22,422,000
- Effective
- 2024-02-15
Exact text from the filing
the Company entered into securities purchase agreements (each, a “Series C Purchase Agreement”) with accredited investors relating to an offering (the “Offering”) and the sale of an aggregate of (i) 17,307 shares of newly designated Series C Preferred Stock
View on SEC.gov